Matthew Arnold

Pfizer named Paul Levesque chief marketing officer for its US primary care business.

Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of 60-some industry digerati have put together guidelines of their own.

Marketing now means digital, digital means mobile and search is no longer the starting point for online promotion. Matthew Arnold charts the trends

Cowed by a fierce and lighting-quick backlash fueled by angry Tweets and Facebook posts, The Susan G. Komen for the Cure Foundation is backpedaling, but is it too late to reverse the reputation damage?

The Healthcare Businesswomen's Association named Ernst & Young global pharma lead Carolyn Buck Luce, calling her "a dedicated leader promoting women's advancement in healthcare."

Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.

J&J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.

Jon Bon Jovi is the latest celebrity pitchman for Pfizer Consumer Healthcare's Advil.

Genentech is sponsoring a flu education campaign the features hereditary etiquette expert Anna Post offering advice to the flu-stricken on keeping the bug to themselves.

With hours to go in 2011, the FDA issued a sneaky draft guidance that many view as the first installment on its long-promised and oft-delayed advice on the use of Internet communications and social media for prescription drug promotion.